{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T07:56:18Z","timestamp":1743062178531,"version":"3.40.3"},"publisher-location":"Totowa, NJ","reference-count":22,"publisher":"Humana Press","isbn-type":[{"type":"print","value":"9781617790942"},{"type":"electronic","value":"9781617790959"}],"license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1007\/978-1-61779-095-9_7","type":"book-chapter","created":{"date-parts":[[2011,5,16]],"date-time":"2011-05-16T16:11:54Z","timestamp":1305562314000},"page":"157-182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Manufacturing of Retroviruses"],"prefix":"10.1007","author":[{"given":"Pedro E.","family":"Cruz","sequence":"first","affiliation":[]},{"given":"Teresa","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Marlene","family":"Carmo","sequence":"additional","affiliation":[]},{"given":"Dagmar","family":"Wirth","sequence":"additional","affiliation":[]},{"given":"Ana I.","family":"Amaral","sequence":"additional","affiliation":[]},{"given":"Paula M.","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Ana S.","family":"Coroadinha","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,4,2]]},"reference":[{"key":"7_CR1_7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1126\/science.270.5235.475","volume":"270","author":"RM Blaese","year":"1995","unstructured":"Blaese, R. M., K. W. Culver, A. D. Miller, C. S. Carter, T. Fleisher, M. Clerici, G. Shearer, L. Chang, Y. Chiang, P. Tolstoshev, J. J. Greenblatt, S. A. Rosenberg, H. Klein, M. Berger, C. A. Mullen, W. J. Ramsey, L. Muul, R. A. Morgan and W. F. Anderson (1995) T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science\n                270, 475\u2013480.","journal-title":"Science"},{"key":"7_CR2_7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0167-7799(99)01416-X","volume":"18","author":"A Mountain","year":"2000","unstructured":"Andrew Mountain (2000) Gene Therapy: the first decade. TIBTECH\n                18, 119\u2013128.","journal-title":"TIBTECH"},{"key":"7_CR3_7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrg1066","volume":"4","author":"CE Thomas","year":"2003","unstructured":"Thomas, C.E., Ehrhardt, A., and Kay, M.A. (2003) Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet\n                4, 346\u2013358.","journal-title":"Nat Rev Genet"},{"key":"7_CR4_7","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1056\/NEJMoa0805817","volume":"360","author":"A Aiuti","year":"2009","unstructured":"Aiuti, A., Cattaneo, F., Galimberti, S., Benninghoff, U., Cassani, B., Callegaro, L., Scaramuzza, S., Andolfi, G., Mirolo, M., Brigida, I., Tabucchi, A., Carlucci, F., Eibl, M., Aker, M., Slavin, S., Al-Mousa, H., Al Ghonaium, A., Ferster, A., Duppenthaler, A., Notarangelo, L., Wintergerst, U., Buckley, RH., Bregni, M., Marktel, S., Valsecchi, MG., Rossi, P., Ciceri, F., Miniero, R., Bordignon, C., Roncarolo, M.G. (2009) Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med. 360, 447\u201358.","journal-title":"N Engl J Med."},{"key":"7_CR5_7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/jnci\/89.1.21","volume":"89","author":"JA Roth","year":"1997","unstructured":"Roth, J. A. and R. J. Cristiano (1997) Gene therapy for cancer: what have we done and where are we going? J Natl Cancer Inst\n                89, 21\u201339.","journal-title":"J Natl Cancer Inst"},{"key":"7_CR6_7","doi-asserted-by":"crossref","unstructured":"Cruz, P.E., Coroadinha, A.S., Rodrigues, T., and Hauser, H. (2008) Production of Retroviral Vectors: from the producer cell to the final product, In Gene and Cell Therapy: Therapeutic Mechanisms and Strategies Taylor & Francis eds. (CRC Press) pp. 17\u201332.","DOI":"10.1201\/9780849387999.ch2"},{"key":"7_CR7_7","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1002\/jgm.499","volume":"6","author":"O-W Merten","year":"2004","unstructured":"Merten, O.-W. (2004) State-of-the-art of the production of retroviral vectors. J Gene Med\n                6, S105\u2013124.","journal-title":"J Gene Med"},{"key":"7_CR8_7","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jbiotec.2006.01.037","volume":"124","author":"AS Coroadinha","year":"2006","unstructured":"Coroadinha, A.S., Schucht, R., Gama-Norton, L., Wirth, D., Hauser, H., and Carrondo, M.J.T. (2006) The use of recombinase cassette exchange in retroviral vector producer cell lines: predictability and efficiency in transgene exchange. J. Biotechnol.\n                124, 457\u2013468.","journal-title":"J. Biotechnol."},{"key":"7_CR9_7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ymthe.2005.12.003","volume":"14","author":"R Schucht","year":"2006","unstructured":"Schucht, R., Coroadinha, A.S., Zanta-Boussif, M.A., Verhoeyen, E., Carrondo, M.J., Hauser, H., and Wirth, D. (2006) A new generation of retroviral producer cells: predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors. Mol Ther\n                14, 285\u2013292.","journal-title":"Mol Ther"},{"key":"7_CR10_7","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jbiotec.2006.07.028","volume":"127","author":"T Rodrigues","year":"2007","unstructured":"Rodrigues, T., Carrondo, M.J., Alves, P.M., Cruz, P.E. (2007) Purification of retroviral vectors for clinical application: biological implications and technological challenges. J Biotechnol\n                127, 520\u201341.","journal-title":"J Biotechnol"},{"key":"7_CR11_7","first-page":"2895","volume":"6","author":"AD Miller","year":"1986","unstructured":"Miller, A.D., Buttimore, C. (1986) Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6, 2895\u20132902.","journal-title":"Mol. Cell. Biol."},{"key":"7_CR12_7","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1128\/jvi.65.5.2220-2224.1991","volume":"65","author":"AD Miller","year":"1991","unstructured":"Miller, A.D., et al. (1991) Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol.\n                65, 2220\u20132224.","journal-title":"J. Virol."},{"key":"7_CR13_7","doi-asserted-by":"crossref","first-page":"7430","DOI":"10.1128\/jvi.69.12.7430-7436.1995","volume":"69","author":"FL Cosset","year":"1995","unstructured":"Cosset, F.L., Takeuchi, Y., Battini, J.L., Weiss, R.A., Collins, M.K. (1995) High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol\n                69, 7430\u20137436.","journal-title":"J Virol"},{"key":"7_CR14_7","unstructured":"Swift, S., Lorens, J., Achacoso, P., Nolan, G.P. (2001) Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. Curr Protoc Immunol., Chapter 10: Unit 10.17C."},{"key":"7_CR15_7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1089\/10430349950018986","volume":"10","author":"G Duisit","year":"1999","unstructured":"Duisit, G., Salvetti, A., Moullier, P., Cosset, F.-L. (1999) Functional characterization of adenoviral\/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines. Hum Gene Ther, 10, 189\u2013200.","journal-title":"Hum Gene Ther"},{"key":"7_CR16_7","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/sj.gt.3301457","volume":"8","author":"M Pizzato","year":"2001","unstructured":"Pizzato, M., Merten, O.W., Blair, E.D., Takeuchi, Y. (2001) Development of a suspension packaging cell line for production of high titre, serum-resistant murine leukemia virus vectors. Gene Ther., 8, 737\u201345.","journal-title":"Gene Ther."},{"key":"7_CR17_7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jviromet.2004.03.007","volume":"119","author":"M Carmo","year":"2004","unstructured":"Carmo, M., Peixoto, C., Coroadinha, A.S., Alves, P.M., Cruz, P.E., Carrondo, M.J.T. (2004). Quantitation of MLV-based retroviral vectors using real-time RT-PCR. J Virol Methods\n                119, 115\u2013119.","journal-title":"J Virol Methods"},{"key":"7_CR18_7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/jgm.1021","volume":"9","author":"T Rodrigues","year":"2007","unstructured":"Rodrigues, T., Carvalho, A., Carmo, M., Carrondo, M.J.T., Alves, P.M., Cruz, P.E. (2007) Scalable purification process for gene therapy retroviral vectors. J Gene Med\n                9, 233\u2013243.","journal-title":"J Gene Med"},{"key":"7_CR19_7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jchromb.2004.09.034","volume":"813","author":"J Transfiguracion","year":"2004","unstructured":"Transfiguracion, J., Coelho, H., Kamen, A. (2004) High-performance liquid chromatographic total particles quantification of retroviral vectors pseudotyped with vesicular stomatitis virus-G glycoprotein. J Chromatogr B Analyt Technol Biomed Life Sci\n                813, 167\u2013173.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"7_CR20_7","doi-asserted-by":"crossref","unstructured":"Schambach, A., Maetzig, T. and BAUM, C. (2008) Retroviral Vectors for Gene and Cell Therapy, In Gene and Cell Therapy: Therapeutic Mechanisms and Strategies Taylor & Francis eds. (CRC Press) pp. 3\u201315.","DOI":"10.1201\/9780849387999.pt1"},{"key":"7_CR21_7","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1021\/bp050294y","volume":"22","author":"PE Cruz","year":"2006","unstructured":"Cruz, P.E., Silva, A.S., Rold\u00e3o, A., Carmo, M., Carrondo, M.J.T., Alves. P.M. (2006) Screening of Novel Excipients for Improving the Stability of Retroviral and Adenoviral Vectors. Biotech. Pro.\n                22, 568\u2013576.","journal-title":"Biotech. Pro."},{"key":"7_CR22_7","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/jgm.1353","volume":"11","author":"M Carmo","year":"2009","unstructured":"Carmo, M., Alves, A., Rodrigues, A.F., Coroadinha, A.S., Carrondo, M.J.T., Alves, P.M., Cruz, P.E. (2009) Stabilization of gammaretroviral and lentiviral vectors: from production to gene transfer. J Gene Med\n                11, 670\u2013678.","journal-title":"J Gene Med"}],"container-title":["Methods in Molecular Biology","Viral Vectors for Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-61779-095-9_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T03:07:09Z","timestamp":1676084829000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-61779-095-9_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"ISBN":["9781617790942","9781617790959"],"references-count":22,"URL":"https:\/\/doi.org\/10.1007\/978-1-61779-095-9_7","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2011]]},"assertion":[{"value":"2 April 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}